{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:30:30Z","timestamp":1791379830530,"version":"4.3.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1DP3DK111802"],"award-info":[{"award-number":["1DP3DK111802"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1DP3DK111802"],"award-info":[{"award-number":["1DP3DK111802"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["105636\/Z\/14\/Z"],"award-info":[{"award-number":["105636\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11892-019-1141-6","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T07:09:09Z","timestamp":1552979349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Genetic Mechanisms Highlight Shared Pathways for the Pathogenesis of Polygenic Type 1 Diabetes and Monogenic Autoimmune Diabetes"],"prefix":"10.1007","volume":"19","author":[{"given":"Matthew B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cerosaletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane H.","family":"Buckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"1141_CR1","unstructured":"Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet (London, England) [Internet]. 1974 Nov 30 [cited 2019 Jan 4];2(7892):1279\u201383. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4139522"},{"issue":"4","key":"1141_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","volume":"47","author":"Suna Onengut-Gumuscu","year":"2015","unstructured":"\u2022\u2022 Onengut-Gumuscu S, Chen W-M, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet [Internet]. 2015 Apr 9 [cited 2019 Jan 4];47(4):381\u20136. Available from: \n                      \n                        http:\/\/www.nature.com\/articles\/ng.3245\n                      \n                      \n                    . Fine-mapped susceptibility loci in T1D and showed that T1D was more genetically similar to antibody-driven autoimmune diseases than non-antibody-associated.","journal-title":"Nature Genetics"},{"issue":"6","key":"1141_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.381","volume":"41","author":"Jeffrey C Barrett","year":"2009","unstructured":"Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet [Internet]. 2009 Jun 10 [cited 2019 Jan 4];41(6):703\u20137. Available from: \n                      http:\/\/www.nature.com\/articles\/ng.381","journal-title":"Nature Genetics"},{"issue":"6","key":"1141_CR4","doi-asserted-by":"publisher","first-page":"e1501678","DOI":"10.1126\/sciadv.1501678","volume":"2","author":"Till F. M. Andlauer","year":"2016","unstructured":"Andlauer TFM, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, et al. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Sci Adv [Internet]. 2016 Jun [cited 2019 Jan 30];2(6):e1501678. Available from: \n                      https:\/\/doi.org\/10.1126\/sciadv.1501678","journal-title":"Science Advances"},{"issue":"4","key":"1141_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H. Erlich","year":"2008","unstructured":"Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes [Internet]. 2008 Apr 1 [cited 2019 Jan 8];57(4):1084\u201392. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18252895","journal-title":"Diabetes"},{"issue":"1","key":"1141_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1056\/NEJMoa1313977","volume":"371","author":"Edwin Liu","year":"2014","unstructured":"Liu E, Lee H-S, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med [Internet]. 2014 Jul 3 [cited 2019 Jan 8];371(1):42\u20139. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24988556","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"1141_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/1096-8628(20001218)95:5<432::AID-AJMG5>3.0.CO;2-7","volume":"95","author":"Mahdi Zamani","year":"2000","unstructured":"Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman JJ. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet [Internet]. 2000 Dec 18 [cited 2019 Jan 8];95(5):432\u20137. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11146462","journal-title":"American Journal of Medical Genetics"},{"key":"1141_CR8","unstructured":"Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet [Internet]. 2010 Jun [cited 2019 Jan 30];42(6):508\u201314. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20453842"},{"key":"1141_CR9","doi-asserted-by":"crossref","unstructured":"Johnson MB, Hattersley AT, Flanagan SE. Monogenic autoimmune diseases of the endocrine system 2016 Oct [cited 2019 Jan 4];4(10):862\u201372. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27474216","DOI":"10.1016\/S2213-8587(16)30095-X"},{"issue":"10","key":"1141_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1707","volume":"5","author":"Kristin A. Hogquist","year":"2005","unstructured":"Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol [Internet]. 2005 Oct 1 [cited 2019 Jan 4];5(10):772\u201382. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16200080","journal-title":"Nature Reviews Immunology"},{"key":"1141_CR11","first-page":"1","volume":"2018","author":"Bingjie Zhao","year":"2018","unstructured":"Zhao B, Chang L, Fu H, Sun G, Yang W. The role of autoimmune regulator (AIRE) in peripheral tolerance. J Immunol Res [Internet]. 2018 Sep 4 [cited 2019 Jan 4];2018:1\u20136. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30255105","journal-title":"Journal of Immunology Research"},{"issue":"4","key":"1141_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng1297-399","volume":"17","author":"Johanna Aaltonen","year":"1997","unstructured":"Aaltonen J, Bj\u00f6rses P, Perheentupa J, Horelli-Kuitunen N, Palotie A, Peltonen L, et al. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet [Internet]. 1997 Dec [cited 2019 Jan 4];17(4):399\u2013403. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9398840","journal-title":"Nature Genetics"},{"issue":"5","key":"1141_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","volume":"265","author":"E. S. Husebye","year":"2009","unstructured":"Husebye ES, Perheentupa J, Rautemaa R, K\u00e4mpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type i. J Intern Med [Internet]. 2009 May [cited 2019 Jan 4];265(5):514\u201329. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19382991","journal-title":"Journal of Internal Medicine"},{"issue":"3","key":"1141_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/ng0793-305","volume":"4","author":"Anneke M. Lucassen","year":"1993","unstructured":"Lucassen AM, Julier C, Beressi JP, Boitard C, Froguel P, Lathrop M, et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet [Internet]. 1993 Jul [cited 2019 Jan 4];4(3):305\u201310. Available from: \n                      http:\/\/www.nature.com\/articles\/ng0793-305","journal-title":"Nature Genetics"},{"key":"1141_CR15","doi-asserted-by":"crossref","unstructured":"Owerbach D, Gabbay KH. Localization of a type I diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene. Diabetes [Internet]. 1993 Dec [cited 2019 Jan 4];42(12):1708\u201314. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8243816","DOI":"10.2337\/diabetes.42.12.1708"},{"issue":"3","key":"1141_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ng0397-293","volume":"15","author":"Alberto Pugliese","year":"1997","unstructured":"Pugliese A, Zeller M, Fernandez A, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet [Internet]. 1997 Mar [cited 2019 Jan 4];15(3):293\u20137. Available from: \n                      http:\/\/www.nature.com\/articles\/ng0397-293","journal-title":"Nature Genetics"},{"issue":"3","key":"1141_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng0397-289","volume":"15","author":"Petros Vafiadis","year":"1997","unstructured":"Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet [Internet]. 1997 Mar [cited 2019 Jan 4];15(3):289\u201392. Available from: \n                      http:\/\/www.nature.com\/articles\/ng0397-289","journal-title":"Nature Genetics"},{"issue":"1","key":"1141_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2337\/db10-0255","volume":"60","author":"Chuan Qi Cai","year":"2010","unstructured":"Cai CQ, Zhang T, Breslin MB, Giraud M, Lan MS. Both polymorphic variable number of tandem repeats and autoimmune regulator modulate differential expression of insulin in human thymic epithelial cells. Diabetes [Internet]. 2011 Jan 1 [cited 2019 Jan 4];60(1):336\u201344. Available from: \n                      https:\/\/doi.org\/10.2337\/db10-0255","journal-title":"Diabetes"},{"key":"1141_CR19","doi-asserted-by":"publisher","unstructured":"Sparks AE, Chen C, Breslin MB, Lan MS. Functional domains of Autoimmune Regulator (AIRE) modulate INS-VNTR transcription in human thymic epithelial cells. J Biol Chem [Internet]. 2016 May 20 [cited 2019 Jan 4];291(21):11313\u201322. Available from: \n                      https:\/\/doi.org\/10.1074\/jbc\n                      \n                    . M116.722488.","DOI":"10.1074\/jbc"},{"key":"1141_CR20","doi-asserted-by":"crossref","unstructured":"Durinovic-Bell\u00f3 I, Wu RP, Gersuk VH, Sanda S, Shilling HG, Nepom GT. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immun [Internet]. 2010 Mar 7 [cited 2019 Jan 4];11(2):188\u201393. Available from: \n                      http:\/\/www.nature.com\/articles\/gene2009108","DOI":"10.1038\/gene.2009.108"},{"issue":"6","key":"1141_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/88694","volume":"2","author":"Kon Ho Lee","year":"2001","unstructured":"Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol [Internet]. 2001 Jun 1 [cited 2019 Jan 4];2(6):501\u20137. Available from: \n                      https:\/\/doi.org\/10.1038\/88694","journal-title":"Nature Immunology"},{"issue":"41","key":"1141_CR22","doi-asserted-by":"publisher","first-page":"14840","DOI":"10.1073\/pnas.1416864111","volume":"111","author":"J. Yang","year":"2014","unstructured":"Yang J, Chow ITIT, Sosinowski T, Torres-Chinn N, Greenbaum CJ, James EA, et al. Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes. Proc Natl Acad Sci USA [Internet]. 2014 Oct 14 [cited 2019 Jan 4];111(41):14840\u20135. Available from: \n                      https:\/\/doi.org\/10.1073\/pnas.1416864111","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7","key":"1141_CR23","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.4049\/jimmunol.1403034","volume":"194","author":"David J. Rawlings","year":"2015","unstructured":"Rawlings DJ, Dai X, Buckner JH. The role of PTPN22 risk variant in the development of autoimmunity: finding common ground between mouse and human. J Immunol [Internet]. 2015 Apr 1 [cited 2019 Jan 4];194(7). Available from: \n                      https:\/\/doi.org\/10.4049\/jimmunol.1403034","journal-title":"The Journal of Immunology"},{"issue":"9","key":"1141_CR24","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1172\/JCI45790","volume":"121","author":"Laurence Menard","year":"2011","unstructured":"Menard L, Saadoun D, Isnardi I, Ng Y-S, Meyers G, Massad C, et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest [Internet]. 2011 Sep 1 [cited 2019 Jan 4];121(9). Available from: \n                      http:\/\/www.jci.org\/articles\/view\/45790","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"1141_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4049\/jimmunol.1102176","volume":"188","author":"T. Habib","year":"2011","unstructured":"Habib T, Funk A, Rieck M, Brahmandam A, Dai X, Panigrahi AK, et al. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol [Internet]. 2012 Jan 1 [cited 2019 Jan 4];188(1). Available from: \n                      https:\/\/doi.org\/10.4049\/jimmunol.1102176","journal-title":"The Journal of Immunology"},{"issue":"5","key":"1141_CR26","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"Pia Leete","year":"2016","unstructured":"Leete P, Willcox A, Krogvold L, Dahl-J\u00f8rgensen K, Foulis AK, Richardson SJ, et al. Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes. Diabetes [Internet]. 2016 May [cited 2019 Jan 4];65(5). Available from: \n                      https:\/\/doi.org\/10.2337\/db15-1615","journal-title":"Diabetes"},{"issue":"11","key":"1141_CR27","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.2337\/db14-0365","volume":"63","author":"Sefina Arif","year":"2014","unstructured":"Arif S, Leete P, Nguyen V, Marks K, Nor NM, Estorninho M, et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes [Internet]. 2014 Nov [cited 2019 Jan 4];63(11). Available from: \n                      https:\/\/doi.org\/10.2337\/db14-0365","journal-title":"Diabetes"},{"issue":"22","key":"1141_CR28","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","volume":"361","author":"Mark D. Pescovitz","year":"2009","unstructured":"Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med [Internet]. 2009 Nov 26 [cited 2019 Jan 4];361(22):2143\u201352. Available from: \n                      https:\/\/doi.org\/10.1056\/NEJMoa0904452","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"1141_CR29","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1096\/fj.11-193672","volume":"26","author":"Klaus G. Schmetterer","year":"2012","unstructured":"Schmetterer KG, Neunkirchner A, Pickl WF. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J [Internet]. 2012 Jun 23 [cited 2019 Jan 4];26(6):2253\u201376. Available from: \n                      https:\/\/doi.org\/10.1096\/fj.11-193672","journal-title":"The FASEB Journal"},{"issue":"7","key":"1141_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"Shimon Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol [Internet]. 2010 Jul 18 [cited 2019 Jan 4];10(7):490\u2013500. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20559327","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"1141_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1084\/jem.20160620","volume":"214","author":"Jiahuan Chen","year":"2017","unstructured":"Chen J, Ganguly A, Mucsi AD, Meng J, Yan J, Detampel P, et al. Strong adhesion by regulatory T cells induces dendritic cell cytoskeletal polarization and contact-dependent lethargy. J Exp Med [Internet]. 2017 Feb [cited 2019 Jan 4];214(2):327\u201338. Available from: \n                      https:\/\/doi.org\/10.1084\/jem.20160620","journal-title":"The Journal of Experimental Medicine"},{"issue":"9","key":"1141_CR32","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.4049\/jimmunol.1501740","volume":"196","author":"Anping Xu","year":"2016","unstructured":"Xu A, Liu Y, Chen W, Wang J, Xue Y, Huang F, et al. TGF-\u03b2\u2013induced regulatory T cells directly suppress B cell responses through a noncytotoxic mechanism. J Immunol [Internet]. 2016 May 1 [cited 2019 Jan 4];196(9):3631\u201341. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27001954","journal-title":"The Journal of Immunology"},{"issue":"12","key":"1141_CR33","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1172\/JCI11679","volume":"106","author":"Talal A. Chatila","year":"2000","unstructured":"Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest [Internet]. 2000 Dec 15 [cited 2019 Jan 4];106(12):R75\u201381. Available from: \n                      http:\/\/www.jci.org\/articles\/view\/11679","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"1141_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/jmedgenet-2012-100759","volume":"49","author":"Eva d'Hennezel","year":"2012","unstructured":"d\u2019Hennezel E, Dhuban K Bin, Torgerson T, Piccirillo CA, Bin Dhuban K, Torgerson T, et al. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet [Internet]. 2012 May 11 [cited 2019 Jan 4];49(5):291\u2013302. Available from: \n                      https:\/\/doi.org\/10.1136\/jmedgenet-2012-100759","journal-title":"Journal of Medical Genetics"},{"key":"1141_CR35","doi-asserted-by":"crossref","unstructured":"Sharfe N, Dadi HK, Shahar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A [Internet]. 1997 Apr 1 [cited 2019 Jan 4];94(7):3168\u201371. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9096364","DOI":"10.1073\/pnas.94.7.3168"},{"issue":"2","key":"1141_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2006.10.007","volume":"119","author":"Amy A. Caudy","year":"2007","unstructured":"Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol [Internet]. 2007 Feb [cited 2019 Jan 4];119(2):482\u20137. Available from: \n                      http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674906021191","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"1141_CR37","doi-asserted-by":"crossref","unstructured":"Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood [Internet]. 2006 May 9 [cited 2019 Jan 4];108(5):1571\u20139. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16645171","DOI":"10.1182\/blood-2006-02-004747"},{"issue":"2","key":"1141_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/cei.12214","volume":"175","author":"L. Bezrodnik","year":"2014","unstructured":"Bezrodnik L, Caldirola MS, Seminario AG, Moreira I, Gaillard MI. Follicular bronchiolitis as phenotype associated with CD25 deficiency. Clin Exp Immunol [Internet]. 2014 Feb [cited 2019 Jan 4];175(2):227\u201334. Available from: \n                      https:\/\/doi.org\/10.1111\/cei.12214","journal-title":"Clinical & Experimental Immunology"},{"key":"1141_CR39","unstructured":"Schwab C, Gabrysch A, Olbrich P, Pati\u00f1o V, Warnatz K, Wolff D, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4\u2013insufficient subjects. J Allergy Clin Immunol. 2018;1\u201315."},{"issue":"6204","key":"1141_CR40","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science (80- ). 2014;345(6204):1623\u20137.","journal-title":"Science (80- )"},{"issue":"12","key":"1141_CR41","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"Desir\u00e9e Schubert","year":"2014","unstructured":"Schubert DD, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med [Internet]. 2014 Dec 20 [cited 2019 Jan 4];20(12):1410\u20136. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25329329","journal-title":"Nature Medicine"},{"issue":"1","key":"1141_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.0105-2896.2006.00419.x","volume":"212","author":"David M. Sansom","year":"2006","unstructured":"Sansom DM, Walker LSK The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev [Internet]. 2006 Aug [cited 2019 Jan 4];212(1):131\u201348. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16903911","journal-title":"Immunological Reviews"},{"key":"1141_CR43","doi-asserted-by":"crossref","unstructured":"Collins A V, Brodie DW, Gilbert RJC, Iaboni A, Manso-Sancho R, Walse B, et al. The interaction properties of costimulatory molecules revisited. Immunity [Internet]. 2002 Aug [cited 2019 Jan 4];17(2):201\u201310. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12196291","DOI":"10.1016\/S1074-7613(02)00362-X"},{"issue":"5","key":"1141_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","volume":"1","author":"Theresa L. Walunas","year":"1994","unstructured":"Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity [Internet]. 1994 Aug [cited 2019 Jan 4];1(5):405\u201313. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7882171","journal-title":"Immunity"},{"issue":"6","key":"1141_CR45","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","volume":"90","author":"Gabriela Lopez-Herrera","year":"2012","unstructured":"Lopez-Herrera G, Tampella G, Pan-Hammarstr\u00f6m Q, Herholz P, Trujillo-Vargas CMM, Phadwal K, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet [Internet]. 2012 Jun 8 [cited 2019 Jan 4];90(6):986\u20131001. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22608502","journal-title":"The American Journal of Human Genetics"},{"key":"1141_CR46","doi-asserted-by":"crossref","unstructured":"Johnson MB, De Franco E, Lango Allen H, Al Senani A, Elbarbary N, Siklar Z, et al. Recessively inherited LRBA mutations cause autoimmunity presenting as neonatal diabetes. Diabetes [Internet]. 2017 Aug [cited 2019 Jan 4];66(8):2316\u201322. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28473463","DOI":"10.2337\/db17-0040"},{"issue":"6246","key":"1141_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aaa1663","volume":"349","author":"B Lo","year":"2015","unstructured":"\u2022 Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science (80). 2015;349(6246):436\u201340 An elegant study that defined the role of LRBA in maintaining tolerance by repurposing a known therapeutic agent, abatacept, simultaneously providing a personalised therapy for patients.","journal-title":"Science (80)"},{"issue":"1","key":"1141_CR48","doi-asserted-by":"publisher","first-page":"217-227.e9","DOI":"10.1016\/j.jaci.2014.10.019","volume":"135","author":"Louis-Marie Charbonnier","year":"2015","unstructured":"Charbonnier A-MM, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol [Internet]. 2015 Jan [cited 2019 Jan 4];135(1):217\u201327. Available from: \n                      https:\/\/doi.org\/10.1016\/j.jaci.2014.10.019","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"1141_CR49","doi-asserted-by":"crossref","unstructured":"De Bruyne M, Bogaert DJ, Venken K, Van den Bossche L, Bonroy C, Roels L, et al. A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive TH17 immunity. J Allergy Clin Immunol [Internet]. 2018 Dec [cited 2019 Jan 4];142(6):1968\u201371. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30193839","DOI":"10.1016\/j.jaci.2018.08.026"},{"issue":"8","key":"1141_CR50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","volume":"46","author":"Sarah E Flanagan","year":"2014","unstructured":"Flanagan SE, Haapaniemi E, Russell MA, Caswell R, Allen HL, De Franco E, et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet [Internet]. 2014 Aug 20 [cited 2019 Jan 4];46(8):812\u20134. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25038750","journal-title":"Nature Genetics"},{"key":"1141_CR51","unstructured":"Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood [Internet]. 2015 Jan 22 [cited 2019 Jan 4];125(4):591\u20139. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25359994"},{"key":"1141_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2017.05.021","volume":"181","author":"Schafiq Nabhani","year":"2017","unstructured":"Nabhani S, Schipp C, Miskin H, Levin C, Postovsky S, Dujovny T, et al. STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds. Clin Immunol [Internet]. 2017 Aug [cited 2019 Jan 4];181:32\u201342. Available from: \n                      https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616304478","journal-title":"Clinical Immunology"},{"issue":"12","key":"1141_CR53","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/1744666X.2018.1531704","volume":"14","author":"Peter Olbrich","year":"2018","unstructured":"Olbrich P, Freeman AF. STAT1 and STAT3 mutations: important lessons for clinical immunologists. Expert Rev Clin Immunol [Internet]. 2018 Dec 2 [cited 2019 Jan 4];14(12):1029\u201341. Available from: \n                      https:\/\/doi.org\/10.1080\/1744666X.2018.1531704","journal-title":"Expert Review of Clinical Immunology"},{"key":"1141_CR54","unstructured":"Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet [Internet]. 2007 Jul 6 [cited 2019 Jan 4];39(7):857\u201364. Available from: \n                      http:\/\/www.nature.com\/articles\/ng2068"},{"issue":"7539","key":"1141_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"Kyle Kai-How Farh","year":"2014","unstructured":"Farh KK-H, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature [Internet]. 2015 Feb 19 [cited 2019 Jan 4];518(7539):337\u201343. Available from: \n                      http:\/\/www.nature.com\/articles\/nature13835","journal-title":"Nature"},{"issue":"7670","key":"1141_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature23875","volume":"549","author":"Dimitre R. Simeonov","year":"2017","unstructured":"\u2022\u2022 Simeonov DR, Gowen BG, Boontanrart M, Roth TL, Gagnon JD, Mumbach MR, et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature [Internet]. 2017 Aug 7 [cited 2019 Jan 4];549(7670):111\u20135. Available from: \n                      https:\/\/doi.org\/10.1038\/nature23875\n                      \n                    . Provides a framework for identifying stimulus-responsive enhancers for genes, independent of exposure to the exposure to the stimulus. This will be key to elucidating the functional effects of many susceptibility loci in autoimmune and other diseases.","journal-title":"Nature"},{"issue":"9","key":"1141_CR57","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.434","volume":"41","author":"Calliope A Dendrou","year":"2009","unstructured":"Dendrou CA, Plagnol V, Fung E, Yang JHM, Downes K, Cooper JD, et al. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet [Internet]. 2009 Sep 23 [cited 2019 Jan 4];41(9):1011\u20135. Available from: \n                      http:\/\/www.nature.com\/articles\/ng.434","journal-title":"Nature Genetics"},{"issue":"12","key":"1141_CR58","doi-asserted-by":"publisher","first-page":"e83811","DOI":"10.1371\/journal.pone.0083811","volume":"8","author":"Karen Cerosaletti","year":"2013","unstructured":"Cerosaletti K, Schneider A, Schwedhelm K, Frank I, Tatum M, Wei S, et al. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients. Jacobson S, editor. PLoS One [Internet]. 2013 Dec 23 [cited 2019 Jan 4];8(12):e83811. Available from: \n                      https:\/\/doi.org\/10.1371\/journal.pone.0083811","journal-title":"PLoS ONE"},{"issue":"9","key":"1141_CR59","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.4049\/jimmunol.1100272","volume":"188","author":"G. Garg","year":"2012","unstructured":"Garg G, Tyler JR, Yang JHM, Cutler AJ, Downes K, Pekalski M, et al. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J Immunol [Internet]. 2012 May 1 [cited 2019 Jan 4];188(9). Available from: \n                      https:\/\/doi.org\/10.4049\/jimmunol.1100272","journal-title":"The Journal of Immunology"},{"key":"1141_CR60","doi-asserted-by":"crossref","unstructured":"Long SA, Cerosaletti K, Wan JY, Ho J-C, Tatum M, Wei S, et al. An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells. Genes Immun [Internet]. 2011 Mar 23 [cited 2019 Jan 4];12(2). Available from: \n                      http:\/\/www.nature.com\/articles\/gene201054","DOI":"10.1038\/gene.2010.54"},{"issue":"11","key":"1141_CR61","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.2337\/db15-0516","volume":"64","author":"Jennie H.M. Yang","year":"2015","unstructured":"Yang JHM, Cutler AJ, Ferreira RC, Reading JL, Cooper NJ, Wallace C, et al. Natural Variation in Interleukin-2 sensitivity influences regulatory T-Cell frequency and function in individuals with long-standing type 1 diabetes. Diabetes [Internet]. 2015 Nov [cited 2019 Jan 4];64(11):3891\u2013902. Available from: \n                      https:\/\/doi.org\/10.2337\/db15-0516","journal-title":"Diabetes"},{"key":"1141_CR62","unstructured":"Ueda H, Howson JMM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature [Internet]. 2003 May 29 [cited 2019 Jan 4];423(6939):506\u201311. Available from: \n                      http:\/\/www.nature.com\/articles\/nature01621"},{"key":"1141_CR63","doi-asserted-by":"publisher","unstructured":"Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, Eliasson M, et al. CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med Genet [Internet]. 2007 Feb 6 [cited 2019 Jan 4];8(1):3. Available from: \n                      https:\/\/doi.org\/10.1186\/1471-2350-8-3","DOI":"10.1186\/1471-2350-8-3"},{"key":"1141_CR64","doi-asserted-by":"crossref","unstructured":"de Jong VM, Zaldumbide A, van der Slik AR, Laban S, Koeleman BPC, Roep BO. Variation in the CTLA4 3\u2019UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes. Genes Immun [Internet]. 2016 Jan 10 [cited 2019 Jan 4];17(1):75\u20138. Available from: \n                      http:\/\/www.nature.com\/articles\/gene201551","DOI":"10.1038\/gene.2015.51"},{"key":"1141_CR65","doi-asserted-by":"crossref","unstructured":"de Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon receptors: biochemistry and biological functions. J Biol Chem [Internet]. 2007 Jul 13 [cited 2019 Jan 7];282(28):20053\u20137. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17502368","DOI":"10.1074\/jbc.R700006200"},{"issue":"1","key":"1141_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","volume":"23","author":"Argyrios N. Theofilopoulos","year":"2005","unstructured":"Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha\/beta) in immunity and autoimmunity. Annu Rev Immunol [Internet]. 2005 Apr [cited 2019 Jan 7];23(1):307\u201336. Available from: \n                      https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115843","journal-title":"Annual Review of Immunology"},{"issue":"7","key":"1141_CR67","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.2337\/db13-1777","volume":"63","author":"R. C. Ferreira","year":"2014","unstructured":"Ferreira RC, Guo H, Coulson RMR, Smyth DJ, Pekalski ML, Burren OS, et al. A Type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes [Internet]. 2014 Jul 1 [cited 2019 Jan 7];63(7):2538\u201350. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24561305","journal-title":"Diabetes"},{"key":"1141_CR68","doi-asserted-by":"crossref","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Prim [Internet]. 2016 Jun 16 [cited 2019 Jan 7];2:16039. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27306639","DOI":"10.1038\/nrdp.2016.39"},{"key":"1141_CR69","unstructured":"Bezalel S, Guri KM, Elbirt D, Asher I, Sthoeger ZM. Type I interferon signature in systemic lupus erythematosus. Isr Med Assoc J [Internet]. 2014 Apr [cited 2019 Jan 7];16(4):246\u20139. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24834763"},{"key":"1141_CR70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaut.2018.08.003","volume":"94","author":"Angela Lombardi","year":"2018","unstructured":"Lombardi A, Tsomos E, Hammerstad SS, Tomer Y. Interferon alpha: The key trigger of type 1 diabetes. J Autoimmun [Internet]. 2018 Nov [cited 2019 Jan 7];94:7\u201315. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30115527","journal-title":"Journal of Autoimmunity"},{"key":"1141_CR71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00452061","volume":"1","author":"AK Foulis","year":"1986","unstructured":"Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. Diabetologia in the United Kingdom. Diabetologia. 1986;1:267\u201374.","journal-title":"Diabetologia"},{"issue":"6","key":"1141_CR72","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2337\/diab.44.6.658","volume":"44","author":"X. Huang","year":"1995","unstructured":"Huang X, Yuang J, Goddard A, Foulis A, James RF, Lernmark A, et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes [Internet]. 1995 Jun [cited 2019 Jan 7];44(6):658\u201364. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7540571","journal-title":"Diabetes"},{"issue":"9","key":"1141_CR73","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2337\/dc10-2274","volume":"34","author":"K. Nakamura","year":"2011","unstructured":"Nakamura K, Kawasaki E, Imagawa A, Awata T, Ikegami H, Uchigata Y, et al. Type 1 diabetes and interferon therapy: a nationwide survey in Japan. Diabetes Care [Internet]. 2011 Sep 1 [cited 2019 Jan 7];34(9):2084\u20139. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21775762","journal-title":"Diabetes Care"},{"issue":"1","key":"1141_CR74","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3748\/wjg.v21.i1.233","volume":"21","author":"Taiba Zornitzki","year":"2015","unstructured":"Zornitzki T, Malnick S, Lysyy L, Knobler H. Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World J Gastroenterol [Internet]. 2015 Jan 7 [cited 2019 Jan 7];21(1):233. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25574096","journal-title":"World Journal of Gastroenterology"},{"issue":"25","key":"1141_CR75","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J. Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood [Internet]. 2016 Jun 23 [cited 2019 Jan 7];127(25):3154\u201364. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27114460","journal-title":"Blood"},{"key":"1141_CR76","doi-asserted-by":"crossref","unstructured":"Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet [Internet]. 2006 Jun 14 [cited 2019 Jan 7];38(6):617\u20139. Available from: \n                      http:\/\/www.nature.com\/articles\/ng1800","DOI":"10.1038\/ng1800"},{"key":"1141_CR77","unstructured":"Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet [Internet]. 2014 May 30 [cited 2019 Jan 7];46(5):503\u20139. Available from: \n                      http:\/\/www.nature.com\/articles\/ng.2933"},{"issue":"5925","key":"1141_CR78","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1167728","volume":"324","author":"S. Nejentsev","year":"2009","unstructured":"Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science [Internet]. 2009 Apr 17 [cited 2019 Jan 7];324(5925):387\u20139. Available from: \n                      https:\/\/doi.org\/10.1126\/science.1167728","journal-title":"Science"},{"issue":"10","key":"1141_CR79","doi-asserted-by":"publisher","first-page":"e1002341","DOI":"10.1371\/journal.pgen.1002341","volume":"7","author":"Deborah S. Cunninghame Graham","year":"2011","unstructured":"Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syv\u00e4nen A-C, R\u00f6nnblom L, et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. McCarthy MI, editor. PLoS Genet [Internet]. 2011 Oct 27 [cited 2019 Jan 7];7(10):e1002341. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22046141","journal-title":"PLoS Genetics"},{"issue":"7","key":"1141_CR80","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/ni.3766","volume":"18","author":"Jacquelyn A Gorman","year":"2017","unstructured":"Gorman JA, Hundhausen C, Errett JS, Stone AE, Allenspach EJ, Ge Y, et al. The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity Nat Immunol [Internet]. 2017 Jul 29 [cited 2019 Jan 7];18(7):744\u201352. Available from: \n                      https:\/\/doi.org\/10.1038\/ni.3766","journal-title":"Nature Immunology"},{"issue":"12","key":"1141_CR81","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.4049\/jimmunol.176.12.7263","volume":"176","author":"M. H. Shaw","year":"2006","unstructured":"Shaw MH, Freeman GJ, Scott MF, Fox BA, Bzik DJ, Belkaid Y, et al. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J Immunol [Internet]. 2006 Jun 15 [cited 2019 Jan 7];176(12):7263\u201371. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16751369","journal-title":"The Journal of Immunology"},{"issue":"4","key":"1141_CR82","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S1074-7613(00)00055-8","volume":"13","author":"Kazuya Shimoda","year":"2000","unstructured":"Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, et al. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity [Internet]. 2000 Oct [cited 2019 Jan 7];13(4):561\u201371. Available from: \n                      http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11070174","journal-title":"Immunity"},{"issue":"30","key":"1141_CR83","doi-asserted-by":"publisher","first-page":"eaau8714","DOI":"10.1126\/sciimmunol.aau8714","volume":"3","author":"St\u00e9phanie Boisson-Dupuis","year":"2018","unstructured":"Boisson-Dupuis S, Ramirez-Alejo N, Li Z, Patin E, Rao G, Kerner G, et al. Tuberculosis and impaired IL-23-dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol [Internet]. 2018 Dec 21 [cited 2019 Jan 14];3(30):eaau8714. Available from: \n                      https:\/\/doi.org\/10.1126\/sciimmunol.aau8714","journal-title":"Science Immunology"},{"issue":"363","key":"1141_CR84","doi-asserted-by":"publisher","first-page":"363ra149","DOI":"10.1126\/scitranslmed.aag1974","volume":"8","author":"C. A. Dendrou","year":"2016","unstructured":"Dendrou CA, Cortes A, Shipman L, Evans HG, Attfield KE, Jostins L, et al. Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. Sci Transl Med [Internet]. 2016 Nov 2 [cited 2019 Jan 7];8(363):363ra149. Available from: \n                      https:\/\/doi.org\/10.1126\/scitranslmed.aag1974","journal-title":"Science Translational Medicine"},{"key":"1141_CR85","doi-asserted-by":"crossref","unstructured":"Gorman JA, Hundhausen C, Kinsman M, Arkatkar T, Allenspach EJ, Clough C, et al. The TYK2-P1104A autoimmune protective variant limits coordinate signals required to generate specialized T cell subsets. Front Immunol. 2019;in press.","DOI":"10.3389\/fimmu.2019.00044"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-019-1141-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-019-1141-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-019-1141-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:00:52Z","timestamp":1589738452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-019-1141-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1141"],"URL":"https:\/\/doi.org\/10.1007\/s11892-019-1141-6","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"19 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"20"}}